Integral Diagnostics, a leading provider of diagnostic imaging services, is headquartered in Australia and operates extensively across major regions including Queensland, Victoria, and Western Australia. Founded in 2006, the company has established itself as a key player in the healthcare sector, focusing on high-quality radiology services. Specialising in a range of imaging modalities such as MRI, CT, and ultrasound, Integral Diagnostics is recognised for its commitment to advanced technology and patient care. The company’s unique approach combines state-of-the-art equipment with a team of highly skilled professionals, ensuring accurate and timely diagnoses. With a strong market position, Integral Diagnostics has achieved significant milestones, including numerous accreditations and partnerships that enhance its service offerings. As a trusted name in the industry, Integral Diagnostics continues to set benchmarks for excellence in diagnostic imaging.
How does Integral Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Integral Diagnostics's score of 18 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Integral Diagnostics reported total greenhouse gas emissions of approximately 588,100 kg CO2e for Scope 1 and about 9,109,500 kg CO2e for Scope 2. This data reflects their operational impact, with Scope 1 emissions primarily arising from direct activities and Scope 2 emissions resulting from purchased electricity. For 2021, the company recorded Scope 1 emissions of about 508,200 kg CO2e and Scope 2 emissions of approximately 7,028,800 kg CO2e. In 2020, the figures were around 432,700 kg CO2e for Scope 1 and about 6,716,500 kg CO2e for Scope 2. This trend indicates a consistent operational footprint, with no reported Scope 3 emissions. Integral Diagnostics has not set specific reduction targets or climate pledges, nor do they appear to have cascaded data from a parent company. Their emissions data is sourced directly from Integral Diagnostics Limited, reflecting their commitment to transparency in reporting. The company’s emissions per patient exam are approximately 0.3 kg CO2e for Scope 1 and about 3.5 kg CO2e for Scope 2, highlighting their operational efficiency in relation to service delivery. As they continue to assess their environmental impact, further commitments to emissions reduction may be anticipated in future reporting.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2022 | |
---|---|---|---|
Scope 1 | 432,700 | 000,000 | 000,000 |
Scope 2 | 6,716,500 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Integral Diagnostics is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.